Drug Class
PD-L1 inhibitor
Type
brand
Active Ingredient
durvalumab
📋Overview
Imfinzi is a medication that belongs to a class of drugs known as immune checkpoint inhibitors. It is primarily used in the management of certain types of cancers, including non-small cell lung cancer and bladder cancer. Imfinzi works by helping the body's immune system recognize and attack cancer cells. Its use is associated with advanced or metastatic disease settings.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Imfinzi
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.